| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/21/2009 | EP2017276A1 Phenyl-carboxamide compounds useful for treating pain |
| 01/21/2009 | EP2017269A2 A pharmaceutical compodition comprising form II crystalline Ritonavir and a preparation thereof |
| 01/21/2009 | EP2017263A1 Heteroarylamide lower carboxylic acid derivative |
| 01/21/2009 | EP2016076A2 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| 01/21/2009 | EP2016075A1 Thiazole derivatives and their use as anti-tumour agents |
| 01/21/2009 | EP2016072A1 Factor xa inhibitors |
| 01/21/2009 | EP2016068A1 Pyrazole derivatives and their use as pi3k inhibitors |
| 01/21/2009 | EP2016067A1 Insecticidal compounds |
| 01/21/2009 | EP2016061A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 01/21/2009 | EP2016047A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP1664026B1 Mitotic kinesin inhibitors |
| 01/21/2009 | EP1626964B1 New benzimidazole derivatives |
| 01/21/2009 | EP1613315B1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/21/2009 | EP1549655B1 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | EP0958291B1 3-heterocyclyl-substituted benzoyl derivatives |
| 01/21/2009 | CN101351463A 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives useful in treatment of TRPV1 related disorders |
| 01/21/2009 | CN101351456A Isoxazolines for controlling invertebrate pests |
| 01/21/2009 | CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 01/21/2009 | CN101347428A 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same |
| 01/21/2009 | CN100453553C Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/21/2009 | CN100453542C Resolution method for 2-hetero ring substituted dihydropyrimidine racemic compounds |
| 01/21/2009 | CN100453532C Substituted anthranilamides for controlling invertebrate pests |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479496 Substituted spiro azabicyclics as modulators of chemokine receptor activity |
| 01/20/2009 | US7479489 Heterocyclic antiviral compounds |
| 01/20/2009 | US7479471 Applying to plants, seeds |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2373484C Use of 1,4-benzothiazepine derivatives as drugs for overcoming resistance to anticancer drugs |
| 01/20/2009 | CA2322204C 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 01/20/2009 | CA2293368C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 01/15/2009 | WO2009009122A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/15/2009 | WO2009008989A1 Modulators of pharmacokinetic properties of therapeutics |
| 01/15/2009 | WO2009007751A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 01/15/2009 | WO2009007749A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 01/15/2009 | WO2009007748A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 01/15/2009 | WO2009007676A2 Biomolecule binding ligands |
| 01/15/2009 | WO2009007415A2 Novel compounds |
| 01/15/2009 | WO2009007399A1 New compounds as hsp90 inhibitors |
| 01/15/2009 | WO2009007098A1 Isothiazole and pyrazole derivatives as fungicides |
| 01/15/2009 | WO2009007074A1 Pyrimidinyl pyridazinone derivates |
| 01/15/2009 | WO2009006959A1 Pyridazinone derivates |
| 01/15/2009 | WO2008125342A3 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 01/15/2009 | WO2008089005A3 Renin inhibitors |
| 01/15/2009 | US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use |
| 01/15/2009 | US20090018338 Treatment of CRTH2-Mediated diseases and conditions |
| 01/15/2009 | US20090018150 5-Ht2b Receptor Antagonists |
| 01/15/2009 | US20090018140 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters |
| 01/15/2009 | US20090018139 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018138 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018124 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same |
| 01/15/2009 | US20090018123 Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation |
| 01/15/2009 | US20090018117 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 01/15/2009 | US20090018091 Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use |
| 01/15/2009 | US20090018087 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
| 01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
| 01/15/2009 | US20090017084 skin-friendly formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects, in particular imidacloprid, for controlling parasitic insects on animals |
| 01/15/2009 | CA2693600A1 Pyridazinone derivatives |
| 01/15/2009 | CA2692945A1 Compounds - 945 |
| 01/15/2009 | CA2692867A1 Pyrimidinyl-pyridazinone derivatives |
| 01/15/2009 | CA2692725A1 Compound - 946 |
| 01/15/2009 | CA2692598A1 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/15/2009 | CA2692528A1 Biomolecule binding ligands |
| 01/15/2009 | CA2692374A1 Isothiazole and pyrazole derivatives as fungicides |
| 01/15/2009 | CA2692331A1 Modulators of pharmacokinetic properties of therapeutics |
| 01/14/2009 | EP2014657A1 Diaminopyrimidines as modulators for an EP2 receptor |
| 01/14/2009 | EP2013204A2 2-aminopyridine analogs as glucokinase activators |
| 01/14/2009 | EP2013203A2 Novel process for production of 5-{2-ý4-(1,2-benzisothiazol-3-yl)-1-piperazinyl¨-ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidone) |
| 01/14/2009 | EP2013197A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists |
| 01/14/2009 | EP2013180A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors |
| 01/14/2009 | EP1532120B1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1300396B1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 01/14/2009 | CN101346374A Pestcidal compositions |
| 01/14/2009 | CN101346370A PDF inhibitors |
| 01/14/2009 | CN101346369A Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 01/14/2009 | CN101346358A Estrogen modulators |
| 01/14/2009 | CN101343269A 1,2,3-thiadiazoles derivants, synthesis and use thereof |
| 01/14/2009 | CN101343268A Thiazole couplet pyrazolone series compound and application of the same as Bcl-2 family protein antagonist |
| 01/14/2009 | CN101343251A Thrombopoietin mimetics |
| 01/14/2009 | CN101343250A Thrombopoietin mimetics |
| 01/14/2009 | CN101342169A Thrombopoietin mimetics |
| 01/14/2009 | CN100451009C Diazosulfide derivative and its synthesis and screening method for inducing anti-disease activity |
| 01/13/2009 | US7478376 Computer program code size partitioning method for multiple memory multi-processing systems |
| 01/13/2009 | US7476742 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476685 Pyridine carboxamide derivatives and their use as pesticides |
| 01/13/2009 | US7476682 N-substituted piperidine derivatives as serotonin receptor agents |
| 01/13/2009 | US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 01/13/2009 | US7476667 Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof |
| 01/13/2009 | US7476663 Substituted thiophene carboxamides |
| 01/13/2009 | CA2440186C Medicinal composition containing 1,3-thiazine derivative |
| 01/13/2009 | CA2287907C Novel orally active iron (iii) chelators |
| 01/13/2009 | CA2237273C Angiogenesis inhibiting pyridazinamines |
| 01/13/2009 | CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
| 01/08/2009 | WO2009006404A2 Heterocyclic compounds useful as raf kinase inhibitors |